Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit

Remdesivir is one of the most promising drugs to treat COVID-19 based on the following facts: remdesivir has a broad-spectrum antiviral mechanism of action; it demonstrated in vitro activity against SARS-CoV-2 and in vivo efficacy in animal models against the similar coronavirus MERS-CoV; its safety...

Descripción completa

Detalles Bibliográficos
Autor principal: Sun, Duxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250281/
https://www.ncbi.nlm.nih.gov/pubmed/32458279
http://dx.doi.org/10.1208/s12248-020-00459-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250281/
https://www.ncbi.nlm.nih.gov/pubmed/32458279
http://dx.doi.org/10.1208/s12248-020-00459-8

Ejemplares similares